Trial Site Detail
Drug: |
XL228 |
|||
|---|---|---|---|---|
Trial: |
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
University of Michigan1500 East Medical Center Dr |
Principal Investigator: |
David Smith, MD |
|---|---|
Contact: |
Nabeela Iqbal 734-232-0759 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
University of Michigan Website: |
https://www.umms.med.umich.edu/engage/disp_pub_main.do |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.